Stay updated on Tislelizumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab Combo in NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision v3.4.3 is added to the record history and revision v3.4.2 is removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedContacts/Locations and Study Status sections were added (version 32) on 2026-02-19 and 2026-02-20. An entry from 2026-02-05 was removed.SummaryDifference0.3%

- Check34 days agoChange DetectedThe latest version adds Contacts/Locations and Study Status (v3.4.2). A government funding notice banner was removed (v3.4.1).SummaryDifference0.9%

- Check42 days agoChange DetectedAdded a government funding notice regarding updates and the NIH Clinical Center status, and updated the page revision to v3.4.1; the previous revision v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check49 days agoChange DetectedThe history view introduces UI enhancements such as a glossary toggle, color-coded additions and deletions in the diff view, and a new revision note (v3.4.0) dated 2026-01-26.SummaryDifference1%

- Check63 days agoChange DetectedThe history now shows that Revision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a minor site version update that does not affect study data or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab Combo in NSCLC Clinical Trial page.